Statin Wars

Rita F. Redberg MD, MSc, FACC
Professor of Medicine
Araxe Vilensky Endowed Chair in Cardiology
Faculty, Philip R Lee Institute for Health Policy Studies
Editor, JAMA Internal Medicine
Director, Inquiry Program
UCSF Division of Cardiology
San Francisco, CA

Nearly one-fourth of American adults take lipid-lowering statin medications. However, more people may be eligible. Statin Wars continue to be underway over whether statins should be used not just for the secondary prevention of cardiovascular disease (CVD), but also primary prevention. 

Event Sponsors
This event is sponsored by Clinical Care Solutions and is not sponsored by industry.